NRGN and Alzheimer disease: However, their real specificity is still a matter of debate, because some authors have found higher levels of CSF Ng in neurodegenerative diseases other than AD, such as Creutzfeldt–Jakob disease (CJD) [38,39] and Parkinson’s disease (PD) [31,40].